GlassScriptPhysician profile
Nisha Kinger
NPI 1609530401
$3,958.84
in general payments reported to CMS, 2019-2025
13 companies · $1,460 in 2025
The $1,460 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $421 · 2023: $668 · 2024: $1,285 · 2025: $1,460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,412.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,061.20 | 2024-2025 | |
| Revance Therapeutics, INC. | $785.25 | 2024-2025 | Daxxify, Daxi |
| Galderma Laboratories, L.P. | $613.52 | 2023-2025 | Dysport |
| Novo Nordisk INC | $334.54 | 2021-2024 | Wegovy |
| Inari Medical, INC. | $278.85 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Silk Road Medical, INC. | $142.90 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Merz North America, INC. | $136.94 | 2023 | Xeomin |
| Abiomed | $119.91 | 2024 | Impella |
| Abbott Laboratories | $111.37 | 2023 | Freestyle Libre 3 |
| Si-Bone, INC. | $109.52 | 2022 | |
| Edwards Lifesciences Corporation | $109.33 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Lucid Diagnostics INC. | $102.14 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.37 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nisha Kinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.